Aortic insufficiency stages: Difference between revisions
(/* Stages {{Cite web | last = | first = | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.full.pdf+html | ...) |
(/* Stages {{Cite web | last = | first = | title = 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary | url = http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000029.full.pdf+html | ...) |
||
Line 50: | Line 50: | ||
|- | |- | ||
| C | | C | ||
| Asymptomatic severe [[ | | Asymptomatic severe [[AR]] | ||
| ❑ | | ❑ Calcific aortic valve disease <br> ❑ Rheumatic valve changes | ||
<br> ❑ Dilated aortic sinuses <br> ❑ [[Infective endocarditis]] with abnormal leaflet closure | |||
| ❑ LV | | ❑ Severe [[AR]] | ||
: ❑ Jet width ≥65% of LVOT | |||
: ❑ [[Vena contracta]] >0.6 cm; | |||
: ❑ Holodiastolic flow reversal in the proximal abdominal aorta | |||
: ❑ RVol ≥60 mL/beat; | |||
: ❑ RF ≥50%; | |||
: ❑ ERO ≥0.3 cm2; | |||
: ❑ [[Aortography|Angiography]] grade 3+ to 4+; | |||
| ❑ C1: Normal [[LVEF]] and mild to moderate LV dilatation <br> ❑ C2: abnormal LV systolic function with decreased LVEF or severe LV dilatation | |||
| ❑ None <br> ❑ Exercise testing to confirm symptom status | | ❑ None <br> ❑ Exercise testing to confirm symptom status | ||
|- | |- | ||
| D | | D | ||
| Symptomatic severe | | Symptomatic severe [[AR]] | ||
| ❑ | | ❑ Calcific aortic valve disease <br> ❑ Rheumatic valve changes | ||
<br> ❑ Dilated aortic sinuses <br> ❑ [[Infective endocarditis]] with abnormal leaflet closure | |||
| | ❑ Severe [[AR]] | |||
| ❑ Exertional [[dyspnea]] | : ❑ Jet width ≥65% of LVOT | ||
: ❑ [[Vena contracta]] >0.6 cm; | |||
: ❑ Holodiastolic flow reversal in the proximal abdominal aorta | |||
: ❑ RVol ≥60 mL/beat; | |||
: ❑ RF ≥50%; | |||
: ❑ ERO ≥0.3 cm2; | |||
: ❑ [[Aortography|Angiography]] grade 3+ to 4+; | |||
| ❑ May occur with normal systolic function or decreased function <br> ❑ Presence of moderate to severe LV dilatation | |||
| ❑ Exertional [[dyspnea]] <br> ❑ Exertional [[angina]] <br> ❑ [[HF]] symptoms | |||
|} | |} | ||
AR indicates aortic regurgitation; ERO, effective regurgitant orifice; HF, heart failure; IE, infective endocarditis; LV, left ventricular; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic dimension; LVOT, left ventricular outflow tract; RF, regurgitant fraction; and RVol, regurgitant volume. | |||
==References== | ==References== |
Revision as of 18:47, 5 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Overview
According to the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease, Aortic insufficiency has 4 stages based on the valve's anatomy and hemodynamics and the patients symptoms.
Stages [1]
STAGE | DEFINITION | VALVE ANATOMY | VALVE HEMODYNAMICS | HEMODYNAMIC CONSEQUENCES | SYMPTOMS |
---|---|---|---|---|---|
A | At risk of AR | ❑ Bicuspid valve ❑ Valve sclerosis ❑ History of rheumatic fever ❑ Infective endocarditis |
❑ None | ❑ None | ❑ None |
B | Progressive AR | ❑ Mild-to-moderate calcification ❑ Rheumatic valve changes
|
❑ Mild AR:
|
❑ Normal LV systolic function ❑ Normal LV volume or mild LV dilation |
❑ None |
C | Asymptomatic severe AR | ❑ Calcific aortic valve disease ❑ Rheumatic valve changes
|
❑ Severe AR
|
❑ C1: Normal LVEF and mild to moderate LV dilatation ❑ C2: abnormal LV systolic function with decreased LVEF or severe LV dilatation |
❑ None ❑ Exercise testing to confirm symptom status |
D | Symptomatic severe AR | ❑ Calcific aortic valve disease ❑ Rheumatic valve changes
|
❑ Severe AR
|
❑ May occur with normal systolic function or decreased function ❑ Presence of moderate to severe LV dilatation |
❑ Exertional dyspnea ❑ Exertional angina ❑ HF symptoms
|
AR indicates aortic regurgitation; ERO, effective regurgitant orifice; HF, heart failure; IE, infective endocarditis; LV, left ventricular; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic dimension; LVOT, left ventricular outflow tract; RF, regurgitant fraction; and RVol, regurgitant volume.
References
- ↑ "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary". Retrieved 4 March 2014.